Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Restless legs syndrome heralding an acute exacerbation of multiple sclerosis.
More than just multiple sclerosis.
A Multiple Sclerosis-Associated Variant of CBLB Links Genetic Risk with Type I IFN Function.
Where is the causal variant? On the advantage of the family design over the case-control design in genetic association studies.
Immunomodulatory activity of interferon-beta.
Fingolimod treatment promotes proliferation and differentiation of oligodendrocyte progenitor cells in mice with experimental autoimmune encephalomyelitis.
Building an RNA Sequencing Transcriptome of the Central Nervous System.
Hematopoietic Stem Cell Therapy for Multiple Sclerosis: Top 10 Lessons Learned.
MicroRNAs as Active Players in the Pathogenesis of Multiple Sclerosis.
Predictors of Conversion to Multiple Sclerosis in Patients with Clinical Isolated Syndrome Using the 2010 Revised McDonald Criteria.
Antigen Microarrays for the Study of Autoimmune Diseases.
Circadian rhythmicity of inflammatory serum parameters: a neglected issue in the search of biomarkers in multiple sclerosis.
Betaferon efficiency indicators in the treatment of relapsing remitting form of multiple sclerosis.
Nabiximols (THC/CBD Oromucosal Spray, Sativex®) in Clinical Practice - Results of a Multicenter, Non-Interventional Study (MOVE 2) in Patients with Multiple Sclerosis Spasticity.
Emotional and neutral verbal memory impairment in Multiple Sclerosis.
Idazoxan reduces blood-brain barrier damage during experimental autoimmune encephalomyelitis in mouse.
Lingo-1 Inhibited by RNA Interference Promotes Functional Recovery of Experimental Autoimmune Encephalomyelitis.
Microstructural changes in the striatum and their impact on motor and neuropsychological performance in patients with multiple sclerosis.
Atrophy and structural variability of the upper cervical cord in early multiple sclerosis.
An update on new and emerging therapies for relapsing-remitting multiple sclerosis.
The two sides of pseudo-bulbar disorder in multiple sclerosis: Comparing one patient's experience with a review of the neurologic literature.
The role of gender and sex hormones in determining the onset and outcome of multiple sclerosis.
Resveratrol augments therapeutic efficiency of mouse bone marrow mesenchymal stem cell-based therapy in experimental autoimmune encephalomyelitis.
Color blindness among multiple sclerosis patients in Isfahan.
Retinal nerve fiber layer thickness in benign multiple sclerosis.
Pages
« first
‹ previous
…
298
299
300
301
302
303
304
305
306
…
next ›
last »